維生素Vitamin K2（MK-4、MK-7、MK-9）
The special effects of VK2
Blood clotting. Vitamin K2 is essential for the carboxylation of glutamate residues in certain proteins, to give carboxyglutamate. This modification allows the protein to bind calcium, an essential event in the blood clotting cascade.
Atherosclerotic. This may be due in part to the geranylgeranyl side chain of vitamin K2 which is thought to inhibit the mevalonate pathway, thus preventing the prenylation of growth factors required for osteoclast activation in much the same way as nitrogen-containing bisphosphonates.
Bone health. Vitamin K2 (menatetrenone) can prevent fractures and sustains lumbar bone mineral density in osteoporosis.
Osteoporosis. Vitamin K2, combined with vitamin D and calcium, has been used primarily as treatment or prevention of osteoporosis.
Leucocythemia. Vitamin K2 and its derivatives induce apoptosis in leukemia cells and enhance the effef aof all-trans retinoic acid.
Blood disorders. Vitamin K2 (menadione) may improve a group of blood disorders known as myelodysplastic syndromes (MDS).
Vitamin K2 is more effective than vitamin K1 with respect to osteoclastogenesis likewise hypocholesterolemic effects and the ability to slow atherosclerotic progression have only been observed with vitamin K2.
Vitamin K2(20),MK-4；CAS: 863-61-6 or 11032-49-8
Vitamin K2(35),MK-7；CAS: 27670-94-6 or 2124-57-4
Vitamin K2(45),MK-9；CAS: 523-39-7
關(guān)鍵字： Vitamin K2;維生素K2;11032-49-8
南京百慕達(dá)生物科技有限公司（湖北鴻福達(dá)生物科技有限公司）成立于2019年，位于六朝古都金陵（江蘇省南京市），公司產(chǎn)品包括化工中間體、醫(yī)藥中間體，染料中間體，精細(xì)化工、植物提取物等等，公司主營(yíng)產(chǎn)品：L-丙交酯CAS:4511-42-6/3,4-二羥基二苯甲酮（10425-11-3）/卡培他濱、氟鐵龍等抗癌藥物中間體/1,2,3-三乙酰氧基-5-脫氧-D-核糖，CAS:62211-93-2/α-甲基葡萄糖甙 97-30-3/磷酸肌酸鈉 922-32-7/ 6,11-二氫二苯并[b,e]氧雜卓-11-酮 4504-87-4/4-氯苯甲酰氨基丙二酸二乙酯 81918-01-6/2-(氯磺?；?-3-甲基苯甲酸甲酯；3-甲基-2-磺酰氯苯甲酸甲酯 126535-26-0/(1S)-1-(2R)-環(huán)氧乙基-2-苯乙基氨基甲酸叔丁酯98760-08-8/鄰苯二甲醛（OPA）|二硫氰基甲烷|2-硫脲嘧啶